For more than 30 years, Drug Consumption Rooms (DCRs) have been implemented in Western countries. These services typically aim to reduce overdose-related morbidity and mortality, prevent the spread of infectious diseases and provide access to a broad range of medical and social support services. As frontline, low-threshold services, DCRs are also often among the first sites where insights into new drug use patterns can, and they, therefore, play an important role in the early identification of new and emerging drug trends. In addition, DCRs may also aim to reduce drug use in public and improve public amenities.

In some countries, DCRs are a well-established and integrated component in responses to drug-related problems. Additionally, a substantial body of practical experience and research evidence has accumulated to support its effectiveness in achieving public health and safety. Yet, the scale of DCR implementation still varies considerably worldwide as they remain contested measures, particularly at the level of political and public debates.

This map shows the current number and location of drug consumption facilities throughout Europe (as of March 2024), incorporating the latest data from the European Network of Drug Consumption Rooms [ENDCR] yearly update. The source data for this map may be found in the following document. The coordinates here are approximate and cannot be used to locate facilities.